Yakult Honsha Co.,Ltd. Share Price

Equities

2267

JP3931600005

Food Processing

Delayed Japan Exchange 06:38:26 13/05/2024 BST 5-day change 1st Jan Change
3,121 JPY -0.48% Intraday chart for Yakult Honsha Co.,Ltd. +1.00% -1.52%

Financials

Sales 2024 * 506B 3.25B 259B Sales 2025 * 519B 3.33B 266B Capitalization 961B 6.16B 492B
Net income 2024 * 50.94B 327M 26.09B Net income 2025 * 52.76B 339M 27.02B EV / Sales 2024 * 1.58 x
Net cash position 2024 * 162B 1.04B 82.97B Net cash position 2025 * 183B 1.17B 93.58B EV / Sales 2025 * 1.5 x
P/E ratio 2024 *
19 x
P/E ratio 2025 *
18.1 x
Employees 29,880
Yield 2024 *
1.76%
Yield 2025 *
1.82%
Free-Float 71.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.54%
1 week+1.00%
Current month+1.07%
1 month+5.44%
3 months+1.86%
6 months-15.95%
Current year-1.52%
More quotes
1 week
3 022.00
Extreme 3022
3 143.00
1 month
2 923.00
Extreme 2923
3 143.00
Current year
2 920.50
Extreme 2920.5
3 334.00
1 year
2 920.50
Extreme 2920.5
5 155.00
3 years
2 675.00
Extreme 2675
5 215.00
5 years
2 407.50
Extreme 2407.5
5 215.00
10 years
2 252.50
Extreme 2252.5
5 215.00
More quotes
Managers TitleAgeSince
President 72 01/04/74
Chief Administrative Officer 72 01/04/77
Director/Board Member - -
Members of the board TitleAgeSince
Director/Board Member 78 31/05/09
Comptroller/Controller/Auditor 72 01/04/74
Chief Administrative Officer 72 01/04/77
More insiders
Date Price Change Volume
13/05/24 3,121 -0.48% 871 800
10/05/24 3,136 +1.29% 1,331,300
09/05/24 3,096 +2.08% 1,710,100
08/05/24 3,033 -1.78% 1,202,600

Delayed Quote Japan Exchange, May 13, 2024 at 06:38 am

More quotes
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
3,136 JPY
Average target price
3,529 JPY
Spread / Average Target
+12.53%
Consensus